Economics What Would a ‘Hard Brexit’ Mean for the United States? If the British fail to negotiate a soft exit from the E.U. American car manufacturers, drugmakers, and banks could all suffer. Elham Mafi-Kreft
News in Brief Trump Complains the FDA Is Slow, but It’s Already Faster to Approve Drugs Than Its Counterpart The issue of whether the Food and Drug Administration approves new medicines fast enough has taken on a… Francie Diep
News in Brief What You Don’t Know About the Cost of Grandma’s Prescription Trump wants to drive down the costs of prescription drugs in the United States, which are much higher… Pacific Standard Staff
News in Brief Spending on Medicare’s Drug Program Is Out of Control Forty-one health providers prescribed more than $5 million in drugs in 2011. Last year, that jumped to 514.… Pacific Standard Staff
News in Brief Why Big Pharma’s Argument for Its High Drug Prices Doesn’t Make Sense America is only middle-of-the-road when it comes to innovation for dollar spent. By Francie Diep (Photo: hopkinsii/Flickr) Drug… Pacific Standard Staff
News in Brief Science Explains Why Prescription Drugs Cost So Much in America And what we can do about it. By Francie Diep (Photo: Joe Raedle/Getty Images) Why do prescription drugs… Pacific Standard Staff
News in Brief The Senate Approved a Huge Opioid Bill, but Will It Work? The Senate approved a sweeping bill last week aimed at combating opioid addiction in the United States. The… Francie Diep
News in Brief Co-Pay Coupons Might Save You Money Now, but They’re Used to Keep Drug Prices High Consumers love saving money using drug copay coupons. But by upending the benefit structure of health insurers, these… Pacific Standard Staff
News in Brief One Nice Meal Can Change a Doctor’s Prescribing Habits Big pharma’s hidden path to doctors’ pens: through their stomachs. By Francie Diep (Photo: Benjamin Horn/Flickr) Sometimes, it’s… Pacific Standard Staff
News in Brief Big Pharma Reveals a Biomedical Replication Crisis The replication crisis extends well beyond the social sciences. Who will save the biomedical scientists? By Kate Wheeling… Pacific Standard Staff